Workflow
揭秘涨停丨最高8连板,这些牛股获资金追捧

Market Overview - On July 18, the A-share market saw a total of 52 stocks hit the daily limit, with 46 stocks remaining after excluding 6 ST stocks, resulting in an overall limit-up rate of 71.23% [1] Top Performers - The highest limit-up order volume was recorded by Renmin Tongtai with 393,600 hands, followed by Shangwei New Materials, Meibang Shares, Zhongse Shares, and Yanhua Intelligent with limit-up orders of 280,700 hands, 222,400 hands, 220,900 hands, and 181,100 hands respectively [2] - Shangwei New Materials achieved an 8-day consecutive limit-up, while Lansheng Shares had 6 consecutive limit-ups, and several other stocks also recorded multiple consecutive limit-ups [2] Significant Transactions - In terms of order amount, 13 stocks had limit-up funds exceeding 100 million yuan, with Shangwei New Materials, Meibang Shares, and Renmin Tongtai leading at 939 million yuan, 519 million yuan, and 364 million yuan respectively [3] - Shangwei New Materials reached a "20cm" limit-up again, becoming the second stock in A-share history to achieve eight consecutive "20cm" limit-ups, following an announcement of a potential acquisition of controlling rights by Zhiyuan Robotics [3] Industry Highlights Lithium Battery Sector - Stocks in the lithium battery sector that hit the limit-up include Jinyuan Shares, Guoji General, Jiuwu High-Tech, and Shengxin Lithium Energy [4] - The futures price of lithium carbonate increased by 2.82% on July 18, with a 17.42% rise over the past 20 trading days [4] Performance Growth - Hai Li Shares is expected to achieve a net profit attributable to shareholders of 30.5 million to 36 million yuan in the first half of the year, representing a year-on-year growth of 625.83% to 756.71% [8] - Yanhua Intelligent anticipates a net profit of 3.5 million to 5.25 million yuan, marking a turnaround from losses [9] - Dongfang Zircon is projected to report a net profit of 25 million to 34 million yuan, also indicating a return to profitability [10] Pharmaceutical Sector - Hancheng Group has 92 types of pharmaceutical products on sale, covering various fields including digestive and respiratory systems [11] - Renmin Tongtai aims to establish a professional health service platform in Heilongjiang Province, focusing on four main business areas [12] - Anglikang's ALK-N001 project is currently in Phase I clinical trials, with approval expected by April 2025 [13] ETF Insights - The Food and Beverage ETF (product code: 515170) has seen a recent decline of 1.40% over the past five days, with a current PE ratio of 20.20 times [15] - The Gaming ETF (product code: 159869) has decreased by 2.12% in the last five days, with a PE ratio of 43.40 times [15] - The Cloud Computing 50 ETF (product code: 516630) has increased by 7.95% over the past five days, with a PE ratio of 110.72 times [16]